MET and cancer: JARID1B activates c-Met in cancer stem cells.c-Met and its ligand HGF/SF are involved in epigenetic dysregulation.SPINT2/HAI-2, an inhibitor of HGF/c-Met signaling, was silenced by promoter methylation in medulloblastoma.